sb 203580 has been researched along with 25-hydroxycholesterol in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (25-hydroxycholesterol) | Trials (25-hydroxycholesterol) | Recent Studies (post-2010) (25-hydroxycholesterol) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 853 | 3 | 243 |
| Protein | Taxonomy | sb 203580 (IC50) | 25-hydroxycholesterol (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.3 | |
| Sterol regulatory element-binding protein 2 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calleros, L; Chiloeches, A; Lasa, M; Toro, MJ | 1 |
1 other study(ies) available for sb 203580 and 25-hydroxycholesterol
| Article | Year |
|---|---|
Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism.
Topics: Animals; Blotting, Western; Cholesterol; Culture Media; Electrophoretic Mobility Shift Assay; Hydroxycholesterols; I-kappa B Proteins; Imidazoles; Luciferases; MAP Kinase Signaling System; Mice; NF-kappa B; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Protein Binding; Pyridines; Recombinant Fusion Proteins; Ribosomal Protein S6 Kinases, 90-kDa; Transcription Factor RelA; Transcriptional Activation; Transfection | 2006 |